相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1
Magdalena Koczkowska et al.
HUMAN MUTATION (2020)
Sex differences in cancer mechanisms
Joshua B. Rubin et al.
BIOLOGY OF SEX DIFFERENCES (2020)
Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation
Magdalena Koczkowska et al.
GENETICS IN MEDICINE (2019)
Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study
Sirkku Peltonen et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Cyclooxygenase-2 expression correlates with development, progression, metastasis, and prognosis of osteosarcoma: a meta-analysis and trial sequential analysis
Shengqun Wang et al.
FEBS OPEN BIO (2019)
Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848
Magdalena Koczkowska et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Emerging genotype-phenotype relationships in patients with large NF1 deletions
Hildegard Kehrer-Sawatzki et al.
HUMAN GENETICS (2017)
Cancer of the Peripheral Nerve in Neurofibromatosis Type 1
Verena Staedtke et al.
NEUROTHERAPEUTICS (2017)
Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1
Elina Uusitalo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model
Tara Williamson et al.
ONCOTARGET (2016)
Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model
Ren-Yuan Bai et al.
CLINICAL CANCER RESEARCH (2015)
High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation
Kitiwan Rojnueangnit et al.
HUMAN MUTATION (2015)
Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis
Ren-Yuan Bai et al.
NEURO-ONCOLOGY (2015)
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor
Nancy Ratner et al.
NATURE REVIEWS CANCER (2015)
Overexpression of Cyclooxygenase-2 in Malignant Peripheral Nerve Sheath Tumor and Selective Cyclooxygenase-2 Inhibitor-Induced Apoptosis by Activating Caspases in Human Malignant Peripheral Nerve Sheath Tumor Cells
Michiyuki Hakozaki et al.
PLOS ONE (2014)
Targeting apoptosis pathways by Celecoxib in cancer
Verena Jendrossek
CANCER LETTERS (2013)
Gender Differences in Cancer Susceptibility: An Inadequately Addressed Issue
M. Tevfik Dorak et al.
Frontiers in Genetics (2012)
Cyclooxygenase-2 Is an Independent Predictor of Poor Prognosis in Uterine Leiomyosarcomas
Chae Hyeong Lee et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme
Ren-Yuan Bai et al.
NEURO-ONCOLOGY (2011)
NF1 Microdeletions in Neurofibromatosis Type 1: From Genotype to Phenotype
Eric Pasmant et al.
HUMAN MUTATION (2010)
Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions
V-F Mautner et al.
JOURNAL OF MEDICAL GENETICS (2010)
Chr 19A/J modifies tumor resistance in a sex- and parent-of-origin-specific manner
Jessica C. Walrath et al.
MAMMALIAN GENOME (2009)
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in Exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation
M. Upadhyaya et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Cyclooxygenase-2 overexpression associated with a poor prognosis in chondrosarcomas
M Endo et al.
HUMAN PATHOLOGY (2006)
An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model
KM Reilly et al.
CANCER RESEARCH (2006)
Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects
KM Reilly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Elevated risk for MPNST in NF1 microdeletion patients
T De Raedt et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2002)
Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis
O Gallo et al.
NEOPLASIA (2001)
The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
AL Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
KM Reilly et al.
NATURE GENETICS (2000)
分享论文
